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Calcineurin Signaling and Minireview
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output. Profound remodeling responses of skeletal mus-
cles are evoked by weight training (hypertrophy) or en-
durance training (increased capacity and efficiency for
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Pathological conditions also provoke remodeling re-Southwestern Medical Center at Dallas
sponses in muscle tissues that initially resemble physio-6000 Harry Hines Boulevard
logical adaptations, but subsequently impair contractileDallas, Texas 75390
performance, ultimately resulting in clinical deteriora-
tion and death. Cardiac hypertrophy associated with
enhanced contractility commonly occurs in the early
Calcineurin, a serine-threonine phosphatase activated
stages of heart disease resulting from hypertension or
by Ca21-calmodulin, participates in signaling pathways valvular dysfunction, from ischemic injury following cor-
important for gene regulation and biological responses onary artery occlusion, or from mutations in genes en-
to external stimuli in many organisms and in many types coding proteins of the sarcomere. Initially, this remodel-
of cells (Crabtree, 1999). Calcineurin-dependent signal- ing response appears to serve an adaptive purpose;
ing events have been studied most intensively in the hyperfunctioning myocytes maintain an equilibrium be-
activation of T lymphocytes to foreign antigens, and tween demand and capacity for contractile work. How-
drugs that inhibit calcineurin activity are in clinical use ever, when the pathological stimulus is unremitting, the
to prevent rejection of transplanted organs. Recently, heart undergoes a transition from a thickened, hypertro-
we and our colleagues advanced the hypothesis that phic state to a thin-walled, dilated morphology. Individ-
calcineurin plays a central role in transducing environ- ual cardiomyocytes remain hypertrophic, but the normal
mental signals that control gene expression and hyper- geometric patterning among myocytes is altered, and
trophic growth in cardiac and skeletal muscles (Chin et myocytes dying of apoptosis or necrosis are replaced by
al., 1998; Molkentin et al., 1998). This notion has stimu- fibrous tissue. This latter form of remodeling response is
lated considerable interest and experimental activity, accompanied by functional deterioration and an inexo-
and not a little controversy. The high level of interest rable course leading to death from circulatory collapse
has been based both on certain striking experimental or lethal dysrhythmia. Skeletal myopathies also are char-
data, and on the potential for manipulation of calcineurin acterized by tissue remodeling and morphological ab-
signaling as a therapeutic measure for common and normalities, but these take different forms than those
devastating forms of human disease. The controversy exhibited by the heart, in large measure because of a
has arisen from apparently discrepant results of experi- capacity for myocyte regeneration that is lacking in the
ments designed to test the importance of calcineurin in heart.
transduction of different signals that evoke remodeling While the causes and consequences of myocyte hy-
responses in striated muscles. Here we provide a brief pertrophy are well known, the underlying signaling path-
summary of major experimental results to date, and offer ways and transcriptional mediators of this response are
some suggestions as to how results that appear discor- less clear. It is also unknown whether the same intracel-
dant may be reconciled. lular pathways control hypertrophy of cardiac and skele-
Physiologic and Pathologic Signals tal myocytes and whether physiologically beneficial hy-
for Muscle Remodeling pertrophy, as occurs in athletes, is dependent on the
Cardiac and skeletal muscles of humans and other ver- same mechanisms as pathologic hypertrophy that fre-
tebrates respond to changes in physiological demands quently progresses to heart failure and sudden death.
by remodeling the architecture of individual myocytes Numerous studies have supported the notion that acti-
and of the tissues in which they reside. These responses vation of intracellular Ca21-dependent signaling path-
can take several forms: changes in overall mass of the ways represents a proximal step in the myocyte hyper-
trophic response, but whether different hypertrophictissue (hypertrophy versus atrophy); changes in spatial
stimuli selectively activate distinct pathways leading torelationships among myocytes and other cellular and
a final common response is unclear.extracellular components of muscle tissues; and repro-
Calcineurin and Cardiac Hypertrophygramming of gene expression to alter specialized meta-
Calcineurin, a heterodimeric protein phosphatase com-bolic and contractile properties of myocytes. Under
posed of a catalytic (A) subunit and a regulatory (B)physiological conditions, muscle remodeling serves to
subunit, resides in the cytoplasm where it is specificallymaintain a balance between environmental demands for
activated by sustained, low-amplitude Ca21 waves (Dol-contractile work and the capability of muscle tissues to
metsch et al., 1997). The Ca21 sensitivity of calcineurinmeet those demands. The heart, for example, increases
signaling may uncouple its activation from the flooddramatically in size during normal postnatal develop-
of intracellular Ca21 accompanying each contraction/ment, or as an adaptation to endurance exercise train-
relaxation cycle in a myocyte.ing, thereby meeting increased requirements for cardiac
In activated T cells, calcineurin dephosphorylates
members of the nuclear factor of activated T cells (NFAT)
family of transcription factors, resulting in their translo-³ To whom correspondence should be addressed (e-mail: eolson@
hamon.swmed.edu). cation to the nucleus where they interact combinatorially
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have been shown to stimulate cardiac hypertrophy, rais-
ing the possibility that hypertrophy may represent sim-
ply a generic response to any sort of growth or stress
stimulus to the heart (reviewed in Chien, 2000). An acti-
vated form of NFATc4 lacking sites for calcineurin de-
phosphorylation is also capable of inducing cardiomyo-
cyte hypertrophy, mimicking activated calcineurin, but
again this does not prove that NFATc4 is the key tran-
scriptional target through which hypertrophic signals
are normally channeled in vivo. It should also be empha-
sized that the above studies, like most studies in the
field, have involved overexpression of constitutively
active signaling molecules under control of the strong
a-myosin heavy chain promoter, which is likely to ex-
ceed the strength of a physiological stimulus, resulting
in possible loss of specificity.
Additional support for the role of calcineurin in cardio-
myocyte growth has come from studies showing that
CsA and FK-506 can block hypertrophic responses in
neonatal cardiomyocytes exposed to certain hypertro-
phic agonists. Similarly, the calcineurin inhibitory pro-
tein, Cabin/Cain, can abrogate the hypertrophic re-
sponse of cardiomyocytes in vitro (Taigen et al., 2000).
Figure 1. Ca21 Signaling Pathways Implicated in Myocyte Remodel- Finally, systemic delivery of CsA or FK-506 to some (but
ing and Hypertrophy not all) transgenic mouse models with hypertrophy can
prevent, and at least partially reverse, cardiac pathology
(Sussman et al., 1998).with other transcription factors such as AP-1 to activate
While the above findings are undisputed, the abilitytranscription through composite DNA binding sites
of CsA to block hypertrophy in vivo in response to pres-(Crabtree, 1999). The immunosuppressant drugs cyclo-
sure-overload, one of the most potent and clinically rele-sporin (CsA) and FK-506, widely used in human trans-
vant stimuli for cardiac growth, has become the subjectplant patients, are highly specific inhibitors of cal-
of intense debate. Several independent studies havecineurin and thereby block T cell activation. Thus, the
reported partial or complete blockade to hypertrophydiscovery that calcineurin signaling was sufficient, and
following aortic constriction in rodents. However, anin some cases necessary, for hypertrophic growth of the
equal number of studies have reported lesser effects ofheart has led to intense scrutiny of the possibility that
CsA on this form of hypertrophy (Chien, 2000). The fact
calcineurin inhibitors might also be useful in treatment
that transplant patients maintained on CsA can develop
of this disease state.
cardiac hypertrophy adds further fuel to this debate.
The pathway for transduction of hypertrophic signals
There is also controversy about the potential elevation
by calcineurin in cardiomyocytes, as originally pro- of calcineurin enzyme activity in biopsies from hypertro-
posed, involved activation of calcineurin in response to phic and failing human hearts (Tsao et al., 2000).
signals known to act via intracellular Ca21 (Molkentin et How can these disparate results be reconciled? We
al., 1998). Calcineurin was shown to dephosphorylate suggest that apparent conflicts on this issue can be
NFATc4, which then translocates to the nucleus where explained on the basis of several considerations. Neither
it associates with the cardiac-restricted zinc finger tran- the observed effects of calcineurin antagonist drugs nor
scription factor GATA4, resulting in synergistic activa- the consequences of massive overexpression of trans-
tion of fetal cardiac genes and a hypertrophic response gene products should be considered as sufficient to
(Figure 1). Binding sites for GATA4 are contained in the define unambiguously the role of calcineurin (or other
control regions of numerous genes activated in hyper- signaling molecules) in clinically relevant muscle remod-
trophic cardiomyocytes. The association of activated eling responses. The administration of antagonist drugs
NFATc4 with GATA4 provided a potential mechanism to intact animals presents many problems as a loss-
for the convergence of Ca21 signaling and cardiac gene of-function strategy on which to base mechanistic con-
regulation, which forms the basis for cardiomyocyte hy- clusions, and the interpretation of transgenic gain-of-
pertrophy. function experiments performed so far is clouded by
What is the evidence that calcineurin is involved in potential artifacts resulting from overexpression and
cardiomyocyte hypertrophy? There is no disagreement loss of substrate specificity of constitutively activated
that activated calcineurin can induce hypertrophic growth signaling molecules such as calcineurin. The powerful
of cardiomyocytes in vitro and that expression of a con- approach of gene disruption for loss-of-function is diffi-
stitutively active form of calcineurin in hearts of trans- cult to apply to this problem because of functional re-
genic mice produces progressive myocardial hypertro- dundancy between different isoforms of calcineurin and
phy followed by dilation, heart failure, and death in a NFAT proteins encoded by distinct genes, and because
sequence that resembles the natural history of hyperten- of the phenotypic consequences of null mutations in
sive or valvular heart disease in humans (Molkentin et these genes in nonmuscle tissues. Nevertheless, carefully
designed genetic manipulations using conditional gain-al., 1998). However, a multitude of signaling pathways
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and loss-of-function approaches should permit more (IGFs) are potent inducers of skeletal muscle hypertro-
definitive conclusions to be drawn. Perhaps even more phy in vivo and in vitro. The finding that CsA can block
importantly, calcineurin-dependent signaling should be hypertrophy of cultured skeletal myocytes, and that acti-
considered as only one of several parallel and interdigitat- vated calcineurin can stimulate hypertrophy, suggests
ing pathways by which muscle cells sense and transduce an important role for calcineurin as a downstream medi-
signals that promote specific remodeling responses. ator of IGF signaling (Musaro et al., 1999; Semsarian et
Specifically with respect to conflicting results from al., 1999). Moreover, IGF-stimulated skeletal myocytes
aortic constriction experiments, many variables may in- show nuclear accumulation of NFATc1 and its associa-
fluence the relative contributions of different hypertro- tion with GATA2, suggesting that cardiac and skeletal
phic response pathways. Subtle differences in anatomic myocytes utilize similar cellular components to control
location and severity of the aortic constriction, or in hypertrophic growth. The involvement of calcineurin in
the age, gender, strain, or general health of laboratory skeletal muscle hypertrophy may explain why transplant
animals may influence outcomes. Surgical mortality or patients maintained on CsA long-term develop a myopa-
drug toxicity may eliminate animals manifesting a partic- thy. Consistent with this conclusion, CsA has recently
ular response from subsequent analyses. Since cal- been shown to prevent load-dependent hypertrophy of
cineurin subunits are expressed at much higher levels skeletal muscle (Dunn et al., 1999). Although calcineurin
in striated myocytes than in T cells, immunosuppressant activation may be necessary for skeletal myocyte hyper-
doses of CsA or FK-506 may produce only incomplete trophy in response to IGF and work load, constitutive
inhibition of calcineurin signaling in muscle tissues. expression of calcineurin in skeletal muscle of trans-
These complexities underscore the importance of fur- genic mice does not result in hypertrophy, suggesting
ther studies of the calcineurin signaling pathway before that additional signals may be required (Naya et al.,
the results of experiments using antagonist drugs can 2000). Calcineurin has also been shown to be required
be interpreted clearly. Clinical applications of drugs that for skeletal muscle differentiation (Friday et al., 2000).
interdict the calcineurin signaling pathway as a means Whether this involves the same signaling components
to prevent heart failure in humans will require that the as the hypertrophic response remains to be determined.
consequences of calcineurin activation in the heart be Skeletal muscle fibers can be generally classified as
understood much more fully, and that some method be
fast or slow twitch, based on their contractile and meta-
devised for drug targeting selectively to the heart while
bolic properties and associated patterns of gene ex-
avoiding immunosuppression and neurotoxicity.
pression (Hughes, 1998). Slow twitch oxidative fibers
A rapidly increasing body of recent data show how
(type I), are involved in sustained, tonic contractilecalcineurin-dependent signaling events amplify, and are
events and maintain intracellular Ca21 concentrations atamplified by, the activity of parallel signaling pathways
relatively high levels (100±300 nM). In contrast, fastin cardiac and skeletal muscles. As a consequence of
twitch glycolytic fibers (type IIb) are used for suddensustained calcineurin activity in hearts of transgenic ani-
bursts of contraction and are characterized by brief,mals, specific isoforms of protein kinase C and c-Jun
high-amplitude Ca21 transients and lower ambient Ca21N-terminal kinase are activated (De Windt et al., 2000).
levels (,50 nM). These properties of skeletal muscleAnother particularly robust and important interaction is
fibers are dependent on the pattern of motor nerve stim-revealed by the collaboration of Ca21, calmodulin-depen-
ulation, such that tonic motor neuron activity promotesdent protein kinase (CaMK) and calcineurin to control
the slow fiber phenotype while infrequent motor neurongene expression and remodeling responses in cardiac
firing results in fast fibers.as well as skeletal myocytes through mechanisms that
With respect to remodeling responses in skeletal mus-target the transcription factor MEF2 (Passier et al., 2000;
cles, calcineurin has been proposed to be an importantWu et al., 2000). In the absence of inducing stimuli, MEF2
transducer in pathways by which different patterns ofproteins bind their cognate recognition motifs within
motor nerve activity establish specialized myofiber sub-promoter/enhancer elements of target genes but fail to
types. Administration of CsA to laboratory animals pro-efficiently activate transcription due to association with
motes some degree of slow-to-fast fiber transformationtranscriptional repressor proteins of the histone deace-
(Chin et al., 1998; Dunn et al., 1999), while forced expres-tylase (HDAC) family (specifically HDAC4 and HDAC5)
sion of a constitutively active form of calcineurin in skel-(Figure 1). The latent transcriptional activity of MEF2
etal muscles of transgenic mice promotes the converseproteins can be unmasked by CaMK activity, through
response, fast-to-slow fiber transformation (Naya et al.,disruption of MEF2:HDAC complexes (Lu et al., 2000).
2000). This viewpoint has been challenged, however, byCaMK is a potent inducer of cardiac hypertrophy and
the observation that slow fiber±specific expression ofsynergizes with the calcineurin/NFAT pathway to evoke
reporter genes in transgenic mice can be driven by en-an especially profound hypertrophic response (Passier
hancer elements devoid of apparent binding sites foret al., 2000).
NFAT proteins (Calvo et al., 1999) and by evidence thatCalcineurin Signaling in Skeletal Muscle
calcineurin signaling can augment expression of glyco-The involvement of calcineurin in cardiomyocyte hyper-
lytic enzymes in cultured myocytes. Different remodel-trophy raises the obvious question of whether a similar
ing responses of skeletal muscle that involve fast-to-pathway might control skeletal muscle hypertrophy or
slow myofiber transformation or hypertrophy also canformation of fast versus slow fibers, which is also known
be, under certain conditions, mutually exclusive, pre-to be dependent on Ca21 signaling. Indeed, several re-
senting an apparent paradox in understanding how cal-cent studies have revealed a central role for calcineurin
in both of these responses. Insulin-like growth factors cineurin can play a primary role in both processes.
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Resolving Current Controversy that ultimately produce different remodeling outcomes
in cardiac and skeletal muscles.Increasingly, research into the mechanisms for muscle
remodeling has revealed both new components of indi-
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In summary, rapid progress has been made in delin-
eating the signaling pathways that influence muscle re-
modeling responses to environmental or pathological
stresses, and multiple layers of regulatory complexity
to the pathways for remodeling myocytes in response
to intrinsic and extrinsic signaling have been identified
(Figure 1). Subtle differences in the relative timing or
intensity of individual primary signals, in specific fea-
tures of the metabolic milieu or initial state of the cell,
or in genetic background may lead to differences in
the degree to which any single pathway is activated
to produce similar remodeling responses (e.g., cardiac
hypertrophy). This discovery process will continue, but
the next phase of work in this field is likely to turn more to
the task of unraveling molecular details of the complex
interactions among diverse sets of signals, transducers,
effectors, primary responses, and secondary responses
